Literature DB >> 24756455

Role of interleukin-6 in regulation of immune responses to remodeling after myocardial infarction.

Mingyuan Huang1, Du Yang, Meixiang Xiang, Jianan Wang.   

Abstract

Myocardial remodeling following myocardial infarction (MI) is emerging as key causes of chronic infarct mortality. Interleukin-6 is a classic pro-inflammatory cytokine needed to mount an effective immune response. It seems that interleukin-6 acts as an important role in the dynamic and superbly orchestrated process of innate immunity after MI. Interleukin-6 timely suppresses of innate immune signals to prevent the catastrophic consequences of uncontrolled inflammation on cardiac geometry and function, and thus tunes myocardial remodeling. A comprehensive understanding of biological processes of interleukin-6 in innate immunity leading to inflammatory response and disease-related ventricular remodeling is helpful to find the solution of chronic heart failure. To accomplish this, we reviewed the articles of interleukin-6 regard to inflammation, innate immunity, and cardiac remodeling. This review focuses on the role of interleukin-6 that dominates cell-mediated immunity, especially on neutrophils, monocytes, macrophages, and fibroblasts. In addition, we will also briefly discuss other inflammatory cytokines involved in this process within the paper.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 24756455     DOI: 10.1007/s10741-014-9431-1

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  133 in total

1.  Mast cells, histamine, and IL-6 regulate the selective influx of dendritic cell subsets into an inflamed lymph node.

Authors:  Wojciech Dawicki; Dunia W Jawdat; Nong Xu; Jean S Marshall
Journal:  J Immunol       Date:  2010-01-18       Impact factor: 5.422

Review 2.  Acquisition of lymphokine-producing phenotype by CD4+ T cells.

Authors:  R A Seder; W E Paul
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

3.  Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice prevents cardiac dysfunction and remodeling after myocardial infarction.

Authors:  Hajime Morimoto; Masafumi Takahashi; Atsushi Izawa; Hirohiko Ise; Minoru Hongo; Pappachan E Kolattukudy; Uichi Ikeda
Journal:  Circ Res       Date:  2006-09-21       Impact factor: 17.367

4.  Parthenolide inhibits STAT3 signaling and attenuates angiotensin II-induced left ventricular hypertrophy via modulation of fibroblast activity.

Authors:  Réka Skoumal; Miklós Tóth; Raisa Serpi; Jaana Rysä; Hanna Leskinen; Johanna Ulvila; Tarja Saiho; Jani Aro; Heikki Ruskoaho; István Szokodi; Risto Kerkelä
Journal:  J Mol Cell Cardiol       Date:  2011-01-09       Impact factor: 5.000

5.  Inhibition of signal transducer and activator of transcription 3 (STAT3) attenuates interleukin-6 (IL-6)-induced collagen synthesis and resultant hypertrophy in rat heart.

Authors:  Saiful Anam Mir; Arunachal Chatterjee; Arkadeep Mitra; Kanchan Pathak; Sushil K Mahata; Sagartirtha Sarkar
Journal:  J Biol Chem       Date:  2011-12-07       Impact factor: 5.157

6.  IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice.

Authors:  D Aderka; J M Le; J Vilcek
Journal:  J Immunol       Date:  1989-12-01       Impact factor: 5.422

7.  New insights into the mobilization and phagocytic activity of dendritic cells.

Authors:  J M Austyn
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

8.  Resident cardiac mast cells degranulate and release preformed TNF-alpha, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion.

Authors:  N G Frangogiannis; M L Lindsey; L H Michael; K A Youker; R B Bressler; L H Mendoza; R N Spengler; C W Smith; M L Entman
Journal:  Circulation       Date:  1998-08-18       Impact factor: 29.690

9.  Interleukin-6/signal transducer and activator of transcription 3 (STAT3) pathway is essential for macrophage infiltration and myoblast proliferation during muscle regeneration.

Authors:  Congcong Zhang; Yulin Li; Yina Wu; Luya Wang; Xiaonan Wang; Jie Du
Journal:  J Biol Chem       Date:  2012-11-26       Impact factor: 5.157

10.  GM-CSF mediates autoimmunity by enhancing IL-6-dependent Th17 cell development and survival.

Authors:  Ivo Sonderegger; Giandomenica Iezzi; Reinhard Maier; Nicole Schmitz; Michael Kurrer; Manfred Kopf
Journal:  J Exp Med       Date:  2008-09-08       Impact factor: 14.307

View more
  18 in total

Review 1.  Cellular immunity and cardiac remodeling after myocardial infarction: role of neutrophils, monocytes, and macrophages.

Authors:  Hisahito Shinagawa; Stefan Frantz
Journal:  Curr Heart Fail Rep       Date:  2015-06

2.  MicroRNA-365 regulates the occurrence and immune response of sepsis following multiple trauma via interleukin-6.

Authors:  Hui Gong; Xiaomin Sheng; Jianhua Xue; Dongbo Zhu
Journal:  Exp Ther Med       Date:  2018-08-22       Impact factor: 2.447

3.  The Role of Gratitude in Spiritual Well-being in Asymptomatic Heart Failure Patients.

Authors:  Paul J Mills; Laura Redwine; Kathleen Wilson; Meredith A Pung; Kelly Chinh; Barry H Greenberg; Ottar Lunde; Alan Maisel; Ajit Raisinghani; Alex Wood; Deepak Chopra
Journal:  Spiritual Clin Pract (Wash D C )       Date:  2015-03

4.  Hesperetin protects against inflammatory response and cardiac fibrosis in postmyocardial infarction mice by inhibiting nuclear factor κB signaling pathway.

Authors:  Bing Wang; Lianghai Li; Ping Jin; Mengqiu Li; Jianguo Li
Journal:  Exp Ther Med       Date:  2017-07-09       Impact factor: 2.447

5.  Cadherin-11 blockade reduces inflammation-driven fibrotic remodeling and improves outcomes after myocardial infarction.

Authors:  Alison K Schroer; Matthew R Bersi; Cynthia R Clark; Qinkun Zhang; Lehanna H Sanders; Antonis K Hatzopoulos; Thomas L Force; Susan M Majka; Hind Lal; W David Merryman
Journal:  JCI Insight       Date:  2019-09-19

Review 6.  Influences of laparoscopic-assisted gastrectomy and open gastrectomy on serum interleukin-6 levels in patients with gastric cancer among Asian populations: a systematic review.

Authors:  Zhen-Bo Shu; Hai-Ping Cao; Yong-Chao Li; Li-Bo Sun
Journal:  BMC Gastroenterol       Date:  2015-04-28       Impact factor: 3.067

7.  Circulating Levels of IL-6 Receptor and gp130 and Long-Term Clinical Outcomes in ST-Elevation Myocardial Infarction.

Authors:  Vibeke N Ritschel; Ingebjørg Seljeflot; Harald Arnesen; Sigrun Halvorsen; Jan Eritsland; Morten W Fagerland; Geir Ø Andersen
Journal:  J Am Heart Assoc       Date:  2016-06-13       Impact factor: 5.501

8.  Cardiac Dysfunction in Association with Increased Inflammatory Markers in Primary Aldosteronism.

Authors:  Jung Soo Lim; Sungha Park; Sung Il Park; Young Taik Oh; Eunhee Choi; Jang Young Kim; Yumie Rhee
Journal:  Endocrinol Metab (Seoul)       Date:  2016-11-03

9.  The regulatory role of IL-6R in hepatitis B-associated fibrosis and cirrhosis.

Authors:  Y Chen; S Yang; Y Peng; Z Yang
Journal:  Braz J Med Biol Res       Date:  2017-09-21       Impact factor: 2.590

10.  Early Changes in Circulating Interleukins and Residual Inflammatory Risk After Acute Myocardial Infarction.

Authors:  Maria E R Coste; Carolina N França; Maria Cristina Izar; Daniela Teixeira; Mayari E Ishimura; Ieda Longo-Maugeri; Amanda S Bacchin; Henrique Tria Bianco; Flavio T Moreira; Ibraim Masciarelli Pinto; Gilberto Szarf; Adriano Mendes Caixeta; Otavio Berwanger; Iran Gonçalves; Francisco A H Fonseca
Journal:  Arq Bras Cardiol       Date:  2020-12       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.